Roulan Abu Hweij

Roulan Abu Hweij practices at Avon Dialysis in Plainfield, Indiana.

Roulan Abu Hweij's NPI, 1942676069, was assigned on August 12, 2015. Roulan Abu Hweij holds Indiana license 01087293A.

Roulan Abu Hweij's primary practice is Avon Dialysis, at 1100 Southfield Dr, Plainfield, IN 46168 in Hendricks County. The practice phone is (317) 209-2544.

Roulan Abu Hweij's primary practice is Avon Dialysis in Plainfield, Indiana. Roulan Abu Hweij is also affiliated with Hendricks Regional Health Danville Hospital. The medical group on file is Hendricks Rheumatology. Dmand AI also links Roulan Abu Hweij to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Roulan Abu Hweij practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Roulan Abu Hweij's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Roulan Abu Hweij's licenses on file in 2 states: Indiana and Ohio.

CMS data shows 611 Medicare services from Roulan Abu Hweij across 10 procedure codes in 2024, for 199 Medicare patients. Medicare paid $59,829 for them.

CMS counts 199 Medicare patients who saw Roulan Abu Hweij in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 3.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Roulan Abu Hweij's median patient age at 76, with 54% women.

In 2024, Roulan Abu Hweij wrote 1,142 Medicare Part D claims for 177 patients. 89% of them were for generic drugs. CMS names the drug for 961 of them, across 24 drugs with 11 or more claims each, at $85,876 in total drug cost. In 2023, CMS named 726 claims across 19 drugs.

Roulan Abu Hweij accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Roulan Abu Hweij in 2017. Roulan Abu Hweij's most frequent co-author is Sami Abuqayyas, MD.

CMS Open Payments shows 95 general payments to Roulan Abu Hweij from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $593.